Newsroom Image

Innate Pharma obtains ISO9001:2000 certification for its research and development activities in the field of immunotherapy

September 2, 2005

This certification marks a new milestone in the maturation of the company, obtained at a time when Innate Pharma is significantly building up its team, enlarging its portfolio of compounds and working on various new industrial partnerships.

Download Area
PR in english